Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.
about
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseAdvantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test.Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.AMPK mediates the initiation of kidney disease induced by a high-fat dietImpact of obesity on kidney function and blood pressure in childrenContributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseBrain metabolic dysfunction at the core of Alzheimer's disease.Emerging global epidemic of obesity: the renal perspective.Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.Noninvasive assessment of target organ injury in children with the metabolic syndrome.Relationships between diabetes and cognitive impairmentRenin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis.MicroRNAs as mediators and therapeutic targets in chronic kidney disease.Prevalence and determinants of the metabolic syndrome among subjects with advanced nondiabetes-related chronic kidney disease in Gran Canaria, Spain.An overview of molecular mechanism of nephrotic syndrome.Measuring the glomerular filtration rate in obese individuals without overt kidney disease.
P2860
Q27021700-1DD8437D-1B50-4BA4-A343-AE84C04492C6Q28259585-E299426E-3DB5-43CC-8F05-154CD0AFD2D6Q33804310-A3A50867-9E08-4A07-B84B-B24B53F10EA6Q35064410-FE6A3431-350C-4FCF-8DA3-9FEF7694110BQ35272259-91422E17-44BB-4870-84CD-90B4AF781BD6Q35567862-8545595D-B341-4C98-8F96-E6F2642FEB21Q35997824-695301E2-32AE-40CD-A783-44E161B1A7A7Q35997881-DFAD987E-EAB4-49EC-90B3-9034994F178CQ36554341-B78A7C34-4F9C-4A4F-940C-515F4996ADB6Q36734070-96ECAE7F-1B90-4F24-90C1-FCE3DAFF61AEQ36902735-BE7ADF9F-654F-4B52-B7B7-9171D5DD3117Q37162219-DB069226-14EE-4919-9B70-8ECF7D69FC8EQ37362676-D6622CAE-B56F-4EBB-88C1-1FBA58619F44Q37707471-C54EDB1C-D965-4E23-A3B7-F24A10E5F216Q37855524-59E57CC4-05C7-4A3E-8C02-FA0F0AEA9B53Q41081436-BE363674-7AA3-478C-B3B4-3D1EE27FA756Q42133283-18A60FE5-27B8-446D-882B-44F44EE16BDDQ55053045-6B72E23A-0C9F-46C3-B5A5-80C3F1A56B2E
P2860
Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@ast
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@en
type
label
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@ast
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@en
prefLabel
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@ast
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@en
P1476
Hypothesis: obesity and the in ...... hypertensive nephrosclerosis'.
@en
P2093
Priscilla Kincaid-Smith
P304
P356
10.1097/00004872-200406000-00001
P577
2004-06-01T00:00:00Z